STEVEN LEWIS: Open Payments
NPI 1427005735 · NARBERTH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 34 payments from 16 companies in 2025. Trend: 2023 $428 · 2024 $541 · 2025 $853
Food & beverage: $813Education: $40
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $103 |
| Neurocrine BioSciences, Inc. | 3 | $87 |
| Alpha Cognition USA, Inc. | 1 | $81 |
| Gilead Sciences, Inc. | 3 | $73 |
| Novo Nordisk Inc | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Verona Pharma, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $35 |
| Dexcom, Inc. | 1 | $29 |
Products named: AUSTEDO XR, Kerendia, INGREZZA, Zunveyl, Wegovy, REXULTI, Ohtuvayre, ELIQUIS.
Industry payments across PA — which companies pay providers there.
